Skip to content
healthcare.dev
Get a free key

VORICONAZOLE

NDC 40032-038, voriconazole, suspension, from Novel Laboratories, Inc..

Product NDC
40032-038
Status
Listed
Labeler
Novel Laboratories, Inc.
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA206799
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/40032-038 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • VORICONAZOLE40 mg/mL

Pharmacologic classes

Azole Antifungal [EPC]; Azoles [CS]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
40032-038-60400320038601 BOTTLE in 1 CARTON (40032-038-60) / 75 mL in 1 BOTTLE (40032-038-00)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/53ecce53-57b8-4af1-b4ac-7d37eb25711f

Use it

Look up 40032-038 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/40032-038 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 40032-038. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.